SB

Sushilaben Babubhai Patel

Active Director Director DIN 09308794
DIN 09308794 First appointment Oct 2021 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Sushilaben Babubhai Patel

Data last updated:

Sushilaben Babubhai Patel is a Director at Mitosis Chemcall Private Limited (since 2021). The company operates in Trading.

DIN 09308794
Primary Designation Director
Industry Trading
First Appointment 05 Oct 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mitosis Chemcall Private Limited U51909GJ2021PTC126118
Director05 Oct 20212021Active

Board colleagues of Sushilaben Babubhai Patel

Directorship timeline

Open interactive timeline →
Mitosis Chemcall Private Limited
Premium access

Shareholding and investment profile for Sushilaben Babubhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sushilaben Babubhai Patel

Sushilaben Babubhai Patel currently holds 1 directorship: Mitosis Chemcall Private Limited (Director, since 05 Oct 2021).

Sushilaben Babubhai Patel was first appointed on 05 Oct 2021 as Director at Mitosis Chemcall Private Limited.

The current boards of Sushilaben Babubhai Patel's companies include Krunal Jigneshkumar Patel (Mitosis Chemcall Private Limited), Kshama Anilkumar Patel (Mitosis Chemcall Private Limited), Mitkumar B Patel (Mitosis Chemcall Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available